Category Archives: Pharmaceuticals & Biotech
Recently, Creative Biogene highlighted its ongoing commitment to basic scientific research, focusing on the selection and cultivation of specific strains to enhance its probiotic development services for customers. New York – Creative Biogene is fortunate to be masters of a science … Continue reading
Creative Biogene Unveils High-Quality Xanthan Gum Solutions for Food and Cosmetic Industries
Creative Biogene has launched its food-grade and cosmetic-grade xanthan gum produced through a precise microbial fermentation process, leveraging the capabilities of Xanthomonas campestris, which is tailored to meet the diverse needs of the food and personal care industries. New York … Continue reading
Creative Biogene Launches High-Quality pegRNA Synthesis Service to Advance Precision Gene Editing
Recently, in response to the growing demands of the biotechnology sector, Creative Biogene proudly announces the launch of its pegRNA Synthesis Service, designed to support cutting-edge prime gene editing applications. Shirley, NY – Dec 30, 2025 – Building from a strong … Continue reading
$5 Stocks Gaining Attention for 2026: EKSO, NDRA, ONTF, FLYE, RDZN See Why Inside
Small-cap “$5” names can move fast—especially when a clear catalyst (FDA/regulatory progress, financing clarity, new product cycles, or an inflection in revenue trends) hits the tape. Here are four tickers investors are keeping on 2026 watchlists, along with what could … Continue reading
$2 Stocks to Watch Now: CETX, SNYR, AEHL, SURG, SOPA, PNPN.V, MYSE & DRMA – See 2026 Expectations
As investors position for 2026, a growing group of sub-$2 and low-priced stocks is drawing attention for one reason: asymmetric upside. These names trade at compressed valuations, yet each sits in a sector where a single catalyst—revenue acceleration, operational execution, … Continue reading
Stocks Under $1: AMIX, TOON, SOAR, SJ, BNRG, PNPNF, PRSO – Double-Digit 2026 Watchlist
As investors look ahead to 2026, several small- and micro-cap stocks are drawing renewed attention due to sector tailwinds, company-specific catalysts, and evolving strategic narratives. Below is a news-style overview of seven companies that market watchers believe could see double-digit … Continue reading
Chinese Biotech Engineer Yang Ge Drives Innovation in Vaccine and Gene Therapy Manufacturing
Ge Yang, a veteran biomedical engineer and global project leader, is the CEO of Tianjushi Engineering Technology Group Co., Ltd. Shanghai Second Branch. As the world continues to prioritize public health resilience after years of pandemic challenges, a new wave … Continue reading
The Story of SINOFN Group Founder Mrs. Liu Guohong (Adapted from CCTV’s “Jin Si Xiao Zao Li Cangzhe de Shangji”) In Cangzhou, Hebei Province, the harvest season for the region’s famous golden‑thread jujubes is the busiest time of year. Farmers … Continue reading
Creative Bioarray is proud to announce the enhancement of its comprehensive safety evaluation services with specialized In Vitro Toxicology and In Vivo Toxicology solutions New York – Dec 26, 2025 – In the pharmaceutical industry, which looks to outsource its product … Continue reading
Recently, Creative Bioarray announced the launch of its sophisticated Fluorescent In Situ Hybridization (FISH)-based clonality analysis service. Shirley, NY – Dec 29, 2025 – As a US-leading biotechnological company, Creative Bioarray proudly develops innovative technologies for the cell biology, pharmaceutical, biotechnology, … Continue reading
